Metabolites and lipids directly reflect biological function and disease state. As the molecular layer closest to phenotype, they capture host and microbial metabolic activity underlying health and disease.
Our metabolomics and lipidomics services for highly multiplexed assays deliver the sensitivity and quantitative precision needed to successfully address broad profiling and discovery studies.
biocrates’ standard high‑multiplex metabolomics and lipidomics profiling services provide broad, quantitative coverage of metabolites and lipids using validated, multiplexed kits. The assays combine extensive pathway coverage with high analytical precision from minimal sample volumes, enabling reproducible metabolic profiling at scale.
These services are well suited for exploratory and comparative studies in biological, translational, and clinical research. They support pathway‑level analysis across core metabolic and lipid networks, enabling robust phenotyping, cohort comparisons, and hypothesis generation in large study designs.
All profiling services are based on standardized, fully quality‑controlled workflows using biocrates kits, ensuring high reproducibility and inter‑study comparability. biocrates provides end‑to‑end scientific support, from study design and sample logistics to data processing and analysis, delivering consistent and reliable results throughout the project lifecycle.
The new standard in quantitative metabolomics.
Quantitative analysis of up to 327 small molecules from 24 biochemical classes.
Quantitative analysis of up to 906 lipids from 25 biochemical classes.
The proven quantitative metabolomics platform focusing on lipidomics.
Balanced coverage of small molecules and lipids.
Coverage of the human metabolism at its core.
Standardized, ring-trial-proven workflows ensure reproducible and comparable results across studies and years.
Quantitative measurement with high analytical precision from minimal sample volumes enable confident interpretation and decision making, even when sample material is limited.
Unique pathway coverage with quantification of up to 1,881 biomarkers delivers deep, systems level biological insights.
Advanced data interpretation with pre-defined, disease-specific metabolism indicators (sums and ratios) enhances group comparison and biological understanding.
End-to-end scientific expert support, built on 20 years of metabolomics experience, guides you across the entire workflow.
1. Sample Preparation
Careful preparation of your samples with standardized protocols.
2. Measurement
LC-MS/MS measurement with optimized, validated methods.
3. Data Processing
Metabolite quantification and quality control.
4. Data Analysis
Statistical analysis and visualization.
5. Interpretation
Pathway analysis and biological interpretation.
M&L Service
The biocrates Quant 1000 assay is a comprehensive, ready‑to‑use solution for quantitative metabolomics and lipidomics profiling, designed to address the complexity of chronic disease, translational research, and systems biology. By enabling the simultaneous quantification of an unprecedented number of small molecules and lipids from a single, minimal‑volume sample, the service provides a robust and scalable foundation for studying metabolic phenotypes across diverse biological contexts.
Built on biocrates’ standardized and validated technology, biocrates Quant 1000 assay offers unique pathway‑oriented coverage spanning core metabolism of host physiology, microbiome‑derived metabolites, and interconnected signaling pathways. Absolute quantification is achieved through extensive use of internal standards and calibrators, ensuring high analytical precision and reproducibility across studies, laboratories, and time points.
The biocrates Quant 1000 assay reflects biocrates’ long‑standing approach to metabolomics: standardized, quantitative, and biology‑driven. By integrating broad pathway coverage with rigorous quality control and seamless end‑to‑end workflows, the service generates reliable, comparable data at scale – supporting applications from biomarker discovery and mechanistic studies to population cohorts and clinical research aimed at transforming the understanding and management of complex diseases.
M&L Service
The biocrates MxQuant assay offers a broad spectrum of small molecules for quantitative metabolomics deciphering microbiome-host interactions and core metabolism. Powered by biocrates’ standardized, quality-controlled, and reproducible metabolomics technology, this ready-to-use kit covers 327 small molecules from 24 biochemical classes. The biocrates MxQuant assay provides researchers with the right solution to gain deeper insights into the connections between hundreds of metabolic pathways.
M&L Service
The biocrates LxQuant assay delivers extensive lipid coverage for rapid discoveries with quantitative lipidomics profiling. Powered by biocrates’ standardized, quality-controlled, and reproducible metabolomics technology, this ready-to-use kit covers 906 lipids from 25 biochemical classes. With up to 1,231 lipid-based biomarkers, researchers are equipped with the right solution to capture a comprehensive picture of membrane, storage and circulating lipids.
M&L Service
biocrates Quant 500 XL assay–based profiling services provide comprehensive, quantitative metabolomics and lipidomics phenotyping for studies requiring broad coverage of lipid classes and a pathway-focused small molecule panel. The service enables a detailed characterization of lipid metabolism alongside small molecule profiling, supporting robust assessment of metabolic and lipid homeostasis from minimal sample volumes.
The service is powered by biocrates’ standardized, quality‑controlled workflows, ensuring high analytical precision, reproducibility, and cross‑study comparability. Absolute quantification is achieved through internal standards and calibrated methods, supporting consistent data generation across laboratories, time points, and longitudinal study designs. The pathway‑oriented coverage supports investigation of cardiometabolic, neurodegenerative, inflammatory, and aging‑related processes, as well as host–microbiome interactions.
As a full‑service offering, biocrates Quant 500 XL assay profiling is supported by end‑to‑end scientific expertise, from study design and sample logistics to data processing and quality control. Integrated data handling using biocrates’ established analysis workflows ensures reliable, standardized results, allowing researchers to confidently apply high‑quality metabolomics and lipidomics data across discovery, translational, and routine research applications.
M&L Service
biocrates Quant 500 assay–based profiling services deliver reliable, quantitative metabolomics phenotyping for studies requiring focused yet comprehensive coverage of metabolic pathways. By combining a well balanced selection of small molecules and lipids, the service enables consistent characterization of central metabolism, lipid metabolism, and host–microbiome interactions from minimal sample volumes. This makes it an efficient solution for academic, translational, and applied research projects.
The service is powered by biocrates’ standardized and quality controlled workflows, ensuring high analytical precision, reproducibility, and comparability across studies and cohorts. Absolute quantification using internal standards and calibration strategies supports consistent data generation across laboratories, batches, and time points, making the service suitable for structured study designs and comparative analyses.
As a full service offering, biocrates Quant 500 assay profiling is supported by end to end scientific expertise, covering study design, sample logistics, data processing, and quality control. Using biocrates’ established analysis workflows, the service delivers standardized and reliable metabolomics data that can be readily applied across discovery driven research, longitudinal studies, and routine metabolic phenotyping applications.
M&L Service
The biocrates p180 assay is a simple and high-throughput tool for basic, clinical, and epidemiological research. The assay provides scientists with highly reproducible metabolomics data to confidently obtain detailed knowledge about the metabolic phenotypes in their studies. The successful results of the assay are demonstrated in hundreds of published articles making it the most frequently chosen metabolomics approach of its kind.
Don’t miss out on the latest from Biognosys Group – sign up to receive the latest news, innovations, and expert insights straight to your inbox.
